Create a free research account to view current pricing and place an order.
How does AOD-9604 work in research models?
AOD-9604 is a modified fragment of the hGH 176-191 region. It is researched for lipolysis-oriented and adipocyte metabolic signaling without the broader anabolic receptor profile associated with full-length human growth hormone.
What is the half-life of AOD-9604?
Half-life: Short acting; human PK limited.
Human PK standardization is limited. Operationally treated as short acting; many research protocols use daily timing to preserve interpretation of metabolic response.
Research dosing reference
250-500 mcg daily; commonly interpreted as a metabolic/lipolysis adjunct.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 250 mcg | 10 units |
| 500 mcg | 20 units |
| 750 mcg | 30 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is AOD-9604 reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 5 mg | 2 mL BAC Water | 0.025 mg/unit |
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Daily administration; morning or pre-activity timing is often preferred for metabolic interpretation.
Beginner escalation
Begin at the low end to evaluate energy, appetite, and GI response before increasing.
Side-effect mitigation
Monitor GI upset, appetite changes, fatigue, injection-site tolerance, and hydration status.
Stack compatibility
Often paired conceptually with GLP/metabolic protocols or mitochondrial agents; avoid adding too many appetite-modulating agents simultaneously.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Commonly structured as 4-12 week metabolic blocks followed by reassessment of energy, appetite, body-composition trend, GI tolerance, and objective need before extension or repeat course.
Frequently asked questions
What is AOD-9604 and how is it studied?
AOD-9604 is a modified fragment of the hGH 176-191 region. It is researched for lipolysis-oriented and adipocyte metabolic signaling without the broader anabolic receptor profile associated with full-length human growth hormone. AOD-9604 is catalogued in the GLP / Metabolic group of this reference and is studied in laboratory and in-vitro models only.
What is known about the half-life of AOD-9604?
Reference half-life for AOD-9604: short acting; human PK limited. Human PK standardization is limited. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is AOD-9604 stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is AOD-9604 reconstituted for laboratory work?
The reference reconstitution for the 5 mg vial is 2 mL BAC Water, which gives a concentration of about 2.5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is AOD-9604 FDA approved?
No. The research-grade AOD-9604 described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
AOD-9604 product overview · AOD-9604 cost · All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration